We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
-0.07%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.74B
AUM Growth
-$46.6M
Cap. Flow
-$15M
Cap. Flow %
-0.55%
Top 10 Hldgs %
20.69%
Holding
3,121
New
80
Increased
374
Reduced
739
Closed
38

Sector Composition

Rank Sector Weight
1 Technology 17.6%
2 Consumer Discretionary 10.75%
3 Financials 10.63%
4 Healthcare 9.44%
5 Industrials 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTMD icon
2526
Utah Medical Products
UTMD
$230M
$27K ﹤0.01%
296
VHT icon
2527
Vanguard Health Care ETF
VHT
$19B
$27K ﹤0.01%
111
-30
-21% -$7.7K
VIS icon
2528
Vanguard Industrials ETF
VIS
$8.5B
$27K ﹤0.01%
148
-36
-20% -$7.06K
AKTS
2529
DELISTED
Akoustis Technologies Inc
AKTS
$27K ﹤0.01%
2,785
GRTS
2530
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$27K ﹤0.01%
2,546
CSTR
2531
DELISTED
CapStar Financial Holdings, Inc
CSTR
$27K ﹤0.01%
1,274
CURO
2532
DELISTED
CURO Group Holdings Corp.
CURO
$27K ﹤0.01%
1,544
SPPI
2533
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$27K ﹤0.01%
12,291
ROCC
2534
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$27K ﹤0.01%
1,007
VEI
2535
DELISTED
Vine Energy Inc.
VEI
$27K ﹤0.01%
1,617
ABUS icon
2536
Arbutus Biopharma
ABUS
$908M
$26K ﹤0.01%
6,124
ANIP icon
2537
ANI Pharmaceuticals
ANIP
$1.73B
$26K ﹤0.01%
781
CATO icon
2538
Cato Corp
CATO
$65.7M
$26K ﹤0.01%
1,550
-480
-24% -$8.02K
CLPT icon
2539
ClearPoint Neuro
CLPT
$463M
$26K ﹤0.01%
1,475
CTKB icon
2540
Cytek Biosciences
CTKB
$621M
$26K ﹤0.01%
+1,231
New +$29K
CTMX icon
2541
CytomX Therapeutics
CTMX
$760M
$26K ﹤0.01%
5,010
FSK icon
2542
FS KKR Capital
FSK
$3.36B
$26K ﹤0.01%
+1,196
New +$26.4K
GNTY
2543
DELISTED
Guaranty Bancshares
GNTY
$26K ﹤0.01%
732
IPI icon
2544
Intrepid Potash
IPI
$490M
$26K ﹤0.01%
831
KNSA icon
2545
Kiniksa Pharmaceuticals
KNSA
$6.1B
$26K ﹤0.01%
2,278
LXRX icon
2546
Lexicon Pharmaceuticals
LXRX
$1.05B
$26K ﹤0.01%
5,367
NVEC icon
2547
NVE Corp
NVEC
$591M
$26K ﹤0.01%
408
RUSHB icon
2548
Rush Enterprises Class B
RUSHB
$9.18B
$26K ﹤0.01%
846
TG icon
2549
Tredegar Corp
TG
$281M
$26K ﹤0.01%
2,145
TLYS icon
2550
Tilly's
TLYS
$121M
$26K ﹤0.01%
1,890

Similar funds

Ameritas Investment Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Ameritas Investment Partners held 3,121 positions worth $2.74B, down 1.7% from $2.79B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 3.8%. Ameritas Investment Partners opened 80 new positions and exited 38, leaving the 3,121-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Ameritas Investment Partners's largest Q3 2021 buy was GameStop: 65,928 shares worth $2.89M.
  • Ameritas Investment Partners added most to iShares Core S&P 500 ETF in Q3 2021, an estimated $3.84M increase.
  • Ameritas Investment Partners's biggest Q3 2021 reduction was Vanguard S&P 500 ETF, cutting an estimated $5.68M.
  • Ameritas Investment Partners fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $2.89M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.74B portfolio in Q3 2021.
  • Ameritas Investment Partners opened 80 new positions and closed 38 in Q3 2021.
  • Ameritas Investment Partners's portfolio value fell 1.7% quarter-over-quarter to $2.74B.

Based on Ameritas Investment Partners's 13F filing for Q3 2021, filed 15 Nov 2021.